
Share on:
The seven largest public orthopedic companies spent $2.3+ billion on R&D in 2019 and 2020, an expense that was about 7% of their combined sales in 2019 and 8% in 2020, according to our estimates. Click the infographic to see R&D investments by dollars and percent of sales for DePuy Synthes, Stryker, Zimmer Biomet and more.
RELATED ARTICLES
AVNA Names Chip Harvill as Senior Business Development Executive
May 05 2025 , Julie A. Vetalice
Lincotek and Promimic Enter Strategic License Agreement
Apr 23 2025 , Julie A. Vetalice
Trump’s Tariffs Offer Opportunity for Supply Chain Improvement
Apr 23 2025 , BONEZONE Editors